Cargando…
Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration
BACKGROUND: As a quality improvement metric, the US Veterans Health Administration (VHA) monitors the proportion of patients with alcohol use disorders (AUD) who receive FDA approved medications for alcohol dependence (naltrexone, acamprosate, and disulfiram). Evidence supporting the off-label use o...
Autores principales: | Del Re, A C, Gordon, Adam J, Lembke, Anna, Harris, Alex HS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716908/ https://www.ncbi.nlm.nih.gov/pubmed/23835352 http://dx.doi.org/10.1186/1940-0640-8-12 |
Ejemplares similares
-
MOVE: weight management program across the veterans health administration: patient- and facility-level predictors of utilization
por: Del Re, Aaron C, et al.
Publicado: (2013) -
Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration
por: Taylor, Emmeline, et al.
Publicado: (2019) -
Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder
por: Kranzler, Henry R., et al.
Publicado: (2021) -
Correction to: Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder
por: Kranzler, Henry R., et al.
Publicado: (2021) -
Risk of future trauma based on alcohol screening scores: A two-year prospective cohort study among US veterans
por: Harris, Alex H S, et al.
Publicado: (2012)